
UPDATE: Congress on Track to Reauthorize the SBIR and STTR Programs
September 21, 2022/by Ayal Ronen
Update on Biden’s $2-Billion Biotechnology Boost
September 21, 2022/by Ayal Ronen
SBIR/STTR Programs Could Expire Sept. 30
September 14, 2022/by Ayal Ronen
Biden Establishes National Biotechnology and Biomanufacturing Initiative with Executive Order
September 13, 2022/by Ayal Ronen
Is Non-Dilutive Funding the Key to Extending Runway in Biopharma and Biotech?
September 12, 2022/by Ayal Ronen
How Non-Dilutive Funding Leads to Equity Investment: The Story of Enalare
August 29, 2022/by Ayal Ronen
Webinar: $7+ Billion in Cancer Research Funding Opportunities 2022
April 20, 2022/by Ayal Ronen
Cancer Research in 2022: More than $7 Billion in Funding Opportunities
April 5, 2022/by Ayal Ronen
$130 Million in Funding Opportunities from PRCRP
April 3, 2022/by Ayal Ronen
PRCRP Priorities for Fiscal Year 2022
April 3, 2022/by Ayal Ronen
CDMRP Funding Opportunities 2022
March 31, 2022/by Ayal Ronen
ALS Research Funding Opportunities from CDMRP in 2022
March 27, 2022/by Ayal RonenSearch
Recent Posts
BioFuture – October 4-6, 2023 NYCMay 31, 2023 - 4:30 pm
RNA Leaders USA Congress – Boston, MA 6-7, 2023May 17, 2023 - 8:24 am
Peer Reviewed Cancer Research Program (PRCRP)April 13, 2023 - 8:18 am
19th Annual Anglonordic Life Science Conference – April 20, 2023 – LondonApril 2, 2023 - 8:53 am
FreeMind supports MedFIT 2023! October 10th, Strasbourg, FranceMarch 30, 2023 - 7:38 am
Categories
- Conferences (187)
- News (23)
- Opinions (42)
- Opportunities (21)
- Presentations (97)
- Uncategorized (33)
- Webinars (60)